Synapsins
Introduction to Synapsins
The nervous system endows every organism with the ability to perceive and appropriately respond to external signals. When the body receives different stimuli, our brains integrate and process information through complex systems of synapses and neurons. Therefore, the molecular mechanism of regulating synaptic function has become a hot spot in the field of neuroscience. Studies have shown that synapses are made up of the presynaptic and postsynaptic compartments, which are connected by different kinds of neurons. In addition, the functions of many members of the synaptic protein family have aroused much attention due to their essential role in synaptic transmission and plasticity. The synapsin family consists of 10 homologous proteins: Syns Ia-b, IIa-b, as well as IIIa-f. In mammals, different subtypes of synapsins are formed by specific gene alternative splicing. For example, SYN1, SYN2, and SYN3 genes have been identified on human chromosome X(XP11), human chromosome 3(3p25), and mice chromosome 22(22q12.3), respectively.
Fig.1 Molecular interactors of synapsins. (Cesca, 2010)
The Structure of Synapsins
Synapsins consist of a highly homologous N-terminal region and multiple variable C-terminal regions. The N-terminal region is composed of three main domains, domain A, B, and C. The C-terminal regions contain various spliced domains, such as domain D, domain E, domain F, and domain I. Among them, domain A is shared by all synaptic proteins. It generally includes highly conserved PKA phosphorylation sites (site 1), CaMKI as well as IV. Domain B is considered to be a connecting region between domain A and domain C. It consists of phosphorylation sites 4 and 5, mitogen-activated protein kinase, and extracellular signal-regulated kinase (Erk). The domain C is a large amino acid region with a size of about 300aa. These sequences are usually highly charged and hydrophobic, and play a critical role in maintaining α-helix and β-slice conformations of synapsins. Domain D can bind to a battery of SH3-containing proteins and several types of protein kinase, such as CaMKII.
Synapsins in the Neurotransmitter Release
Identifying the synapse proteins is one of the key issues in revealing the mechanism of neurotransmitter release. Pilot studies have demonstrated that many synapsins located at the end of the synapse are thought to be involved in the management of synaptic vesicle cycling. In general, synapsins are one of the most abundant neuron-specific proteins in synaptic vesicles. Moreover, synapsins can interact with a series of synaptic vesicle-associated proteins to help stabilize the bilayer structure of phospholipids and maintain vesicle integrity and size uniformity. Furthermore, recent studies have indicated that synapsins can be treated as ATP-using enzymes that can bind ATP with high affinities. Besides, synapsins can mediate the process of vesicle exocytosis. Meanwhile, disruption of synapsin function may increase the release of neurotransmitters. As a result, a group of synapsin-deficient models has been generated for selectively reducing the number of vesicles that are far from the plasma membrane.
Creative Biolabs concentrates on promoting the understanding of the function of synapsins in secretion and vesicle recycling. We will combine the advanced analysis tools with incredible technologies around the world to boost novel synapsin isoforms in unprecedented ways. Particularly, our scientists specialized in synapsin studies will work with you to develop the most appropriate strategy that will offer reproducible data for your research. If you are interested in our services, please feel free to contact us for closer communication to learn how we can be involved in your project. Separate services or integrated end-to-end solutions are all welcomed.
Reference
- Cesca, F.; et al. The synapsins: key actors of synapse function and plasticity. Progress in neurobiology. 2010, 91(4): 313-348.
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Rat Muller Cell (Cat#: NCL2110P040)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)